[
  {
    "@id": "http://example.org/fda/1897486392564975113",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/384081700434397511",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non-Sterility: Out of specification results for the sterility test for microbial contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5223673382965262546",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/814128516062705004",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5611410291934059589",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep\" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month expiry. Stability studies indicate that the impacted lots, if stored at 30Â¿C/75% relative humidity continuously beyond 12 months, may exhibit growth of Aspergillus penicillioides."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2087459445908410549",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6739715503406538176",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5703919552904791628",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3387603055611786318",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1157758995313714041",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7898922859350630757",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7645717689731015436",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: ACETAMINOPHEN, CHEW Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD49423_1, EXP: 5/16/2014;  ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003101, EXP: 6/13/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD30028_1, EXP: 5/8/2014;  TACROLIMUS,"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6285672385241867170",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2604408822254990765",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3210046755733514833",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5281144068125841438",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Flurandrenolide is subpotent."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2585397172436601971",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Product does not contain SPF that is declared on the label."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6615831894161208796",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling:Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as    MISOPROSTOL, Tablet, 200 mcg, NDC 59762500801, Pedigree: AD21965_13, EXP: 5/1/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD56917_7, EXP: 5/21/2014;  LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD73627_17, EXP: 5/30/2014;  LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: W003216"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6220027198663437853",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4147125082307404670",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2721211413405153959",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured under conditions that could impact its product quality."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/181669137180219558",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4375650157027340260",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup:CYANOCOBALAMIN, Tablet, 500 mcg was mislabled as SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: W002859, EXP: 6/7/2014.  and may have potentially been mislabeled as one of the following drugs:  VITAMIN B COMPLEX W/C, Tablet, 0, NDC 00536730001, Pedigree: AD52993_7, EXP: 5/20/2014;  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD30180_22, EXP:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1646071971136916371",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8591485834352018879",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4760890197892112870",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3166772104302525452",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2513335163414514861",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations: Products were stored outside the drug label specifications."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7889868166062486230",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:  Bag has the potential to leak."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5862004479291370542",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4398828639649045363",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "GMP Deviation; A foreign stopper was observed during packaging of a lot of product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7716552703488206757",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7366656642825551563",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2146820948363689970",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3860153084416413918",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: Out of specification for assay at the 12-month timepoint."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4873357824879196798",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of particulate matter.one confirmed  customer report of particulate matter within two semi-rigid bottles identified prior to use"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7994568319266834322",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5690688283863114187",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6596645292575076963",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6820071363974839316",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Media fill with bacterial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4788675635256854447",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3683361109687816591",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8659539876560996281",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5950012287356101220",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8151149890906561762",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent: Out of specification for assay at the 12-month time point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6202238176598944412",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6591789956895921793",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7850115000010482902",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specification; out of specification results for carbon dioxide"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4346811005402660475",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3238216632870403251",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6390140328665765837",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3203142304938622972",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7604283748251002757",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4155065152592579031",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2437068810768017052",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3134639341739737510",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as    PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD22845_1, EXP: 4/30/2014;  LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD73525_49, EXP: 5/30/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2912928930397201981",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6070568976331964791",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/179676865222124442",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2188432617673755329",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3961392900059836966",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination of non-sterile product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3111877544215018650",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1037904823850250812",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3204354474524368601",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2858168771539071938",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7384192574707506022",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5802790398249100682",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1174615022801221486",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6779045115039554637",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1977871880864803465",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4915135217151825180",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2350899368413010206",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: FDA analysis of this product found it to contain undeclared steroids and steroid-like substances making this an unapproved new drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5297499532472708739",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labelling: Missing label."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2290531880430569568",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7592349378230711874",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack Of Assurance Of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8934674337478009664",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5500308585260750163",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3051435568889263899",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8761053859546105293",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4961691475717183597",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: Temperature abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3267497971674868587",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7593616477996465105",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1939670474922426702",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3421464731706914491",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/955339659132797166",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4726524195710549224",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3446471927468073458",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1500757665592782720",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8584380166926631222",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5657611257221627394",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6674583111647009641",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3056941766737402743",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8477653267908515993",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4478838821625586106",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016.  The correct expiry date is 09/2016."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5565693097234589125",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4218228935831673609",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6067345253356013953",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3511907476530417020",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate matter. Recall due to presence of unknown particulate matter."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6123860992453410513",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8978848376465809181",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5900744193658228783",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross contamination with other products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8130262607902054935",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup:MINOXIDIL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug:  methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD52778_43, EXP: 5/20/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5786190066212685328",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2166196728077041198",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5089471053606457807",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/865608484984024924",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls (lack of assurance of conformity to specifications)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8066816553310098258",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: High out of specification results for related compounds."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7622867679896580283",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2984207272397948968",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5062196777165891174",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Sub-Potent Drug: Out of specification for assay at the 24 month interval."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2187329978880623526",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5543349536102650131",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7739252233620817028",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2834377656840734409",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent; Hydrochlorothiazide"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2774179521716024027",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, making AMPD GOLD an unapproved drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/40524938456871169",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6658360316564555471",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm went out of business and could no longer continue stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6646779126803047045",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2415290094488947825",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7395879652974158428",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; product has the potential to leak."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4344357535919148593",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3185302239412791318",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "FAILED CONTENT UNIFORMITY SPECIFICATIONS"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/416104188364119155",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9011284475972501580",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6344935714792076254",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl 5 mg tablets."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3882588970850523105",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4970090721663817234",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5463466138591010752",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Container: Leaking containers."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1559866602416670158",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2240387985156564390",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4017699896438512588",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2179026525996657757",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4557493502924079406",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8412183792131469114",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7617884418710164569",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5844514905704261192",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non-Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7610864536928855936",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6561490618600331028",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/58162533981096283",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3847654338540877244",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7893163290718960111",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Stability Data Does Not Support Expiry"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5907249398687717953",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8969930053822693516",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1655000515399706742",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3023518649065572758",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: Out of specification for impurities."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8921121887376527129",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/219279194860127750",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Impurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/694549865638933056",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4245305720532755595",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2248661098883559703",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3486415720845499945",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: recalled lots may have higher concentration of ibuprofen."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7386282713951254803",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications:Out-of-specification results observed for viscosity during stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7864807584530344732",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Package Insert"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3292556835417591229",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7489342735899300993",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1310862417664708363",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Presence of NDMA impurity detected in product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4086083399613251588",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5036334514835396096",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6324121879583560650",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3261929987364887233",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3848978960535033313",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7395120316719566126",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5975914469440740456",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8864217284548117099",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8218485386282252009",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1979897119976148954",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7058022417693223705",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/147079419507402646",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3355456004593439874",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Out-of-specification test results obtained for identification testing based on HPTLC analysis."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1299052528111628195",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non Sterility: Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2908127307755271887",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/493054932092291667",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: There are also CGMP Deviations."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4499440969828641411",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5672459586555024748",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8376932507743173970",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm went out of business and could no longer continue stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2447020681124857802",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Delivery System"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5861470992137626602",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4170167411207141712",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6632254654122552851",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7844786567003378540",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3571207339052060897",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6477651893248341312",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7463831124132784153",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1443857192782330487",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2659203345960568091",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5177900552097081525",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA; product labeled to contain 0.56% methanol making it an unapproved new drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1832401432115232977",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3998226226470284508",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Control"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7093880530978191192",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: Silicone"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2861658757770858395",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Potential leakage of bags."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5791359471110924336",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6437993686049701439",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3666104987526979386",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3596548952960612396",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/601280916201586996",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5412940737425986246",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3850700804033629895",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5010576779703374844",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1825619882210364454",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/544218057041155072",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1315141679511226287",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2520505044943007248",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4502163736600315106",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3879450826944235769",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6577671950966881216",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2471728450546587796",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6058470966368382925",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2138199202229148759",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Container: Repetitive complaints received indicating pump not working."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5721101016892001380",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7448981148540570954",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4405402144467774050",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7306515815272079455",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5015203132137530886",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8478545332244712024",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility: Lack of validation data for sanitization cycles"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/412761485132398469",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Tablet/Capsule Specifications: Broken tablets"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3231271667348113452",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6999866521459425431",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5128625117207820061",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5620809164419447569",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6774284630670253980",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/822065451995172525",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective container: products are packaged in pouches which may not have been fully sealed"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3867545482205271616",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: Two lots failed specification for unknown impurity at the 24 month stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4244269446893543032",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6895855202748201565",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1723451817026207674",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8925976648757933676",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7926081000775741449",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: There are also CGMP Deviations."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8548358030071668990",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6967552668902703089",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3074593630675410906",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: Out Of Specification (OOS) result for Assay."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7181186276996619374",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6617486493720301872",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6358868119992887589",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations; lack of quality assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6804026157138322436",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7613468707050326929",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/349952965678531528",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non-Sterility; mold contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8644503523443224197",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4025920211987324500",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8021671372545143323",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7981858178983219092",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm did not adequately investigate customer complaints."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5040708705614820339",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1356070627840597646",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1121034210945637569",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products not manufactured under current good manufacturing practices."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1272650815514195936",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3956845036673805252",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/367732347997371290",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2891884722807724437",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm did not adequately investigate customer complaints."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6989254231324878005",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7524268140387362390",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8633674674474736654",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and  one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3505620858739787051",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/524001158104578457",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8238472523840397367",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6288127283011466454",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non-Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2489972811354781569",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1939894870249384041",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8724357199806671045",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8647596829105739892",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: out of  specification test results for the norethindrone impurity."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4405922135090031232",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5512224436346802251",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5173736741571515042",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/678697884453403886",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1871343900020037406",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1928468155405670886",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3144607871300739461",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/776057029063811243",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1707404593015143996",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/33746005393324362",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications; out of specification for Related Compound"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6498143986517988148",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1341468551903622727",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Content Uniformity Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3337889018660385238",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3788392631936515869",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1157611713948682394",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5417664679205241391",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8226254148337096749",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4998519183063738309",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3756325261639667478",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7649651296643174304",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications:OOS for unknown impurity."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5481585765602254140",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/76308304491528493",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6586354867033757226",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/666342373472663903",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7465698963587542716",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7774107049658344608",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3292010419214146011",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5381334668396065514",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: low test results at the 18 month time-point"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5696566402554902947",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1201385077615987523",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3104292743355712900",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/398713013471504612",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5303975491330534363",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Control"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/718695925851371717",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm went out of business and could no longer continue stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7162405059949436568",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5397927486643087974",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1818728301497308087",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7151230533610376950",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7195649527623796544",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: Temperature abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2666576358243555232",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3414762844157630710",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; medication was sterilized with a recalled filter"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5207682165290960185",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8579179636244859683",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed dissolution specifications - low dissolution  results at S3 stage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7188674135987218275",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Bags have the potential to leak."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5632550269913311997",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/597204405460573759",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/354073496021671299",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4963507298550423603",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: recalling drug products following an FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8098353610739422367",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8151484814589467336",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/407320578040319787",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex.  The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex.  The above listed product codes and batches being recalled have stoppers containing natural rubber latex."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/868715377019234251",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8912586762256390053",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2248421706548036",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7733637645331361270",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7192617236412831821",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6449620314837304768",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Wrong Bar Code; Bar code scans as 0.15% Potassium Chloride in 0.9% Sodium Chloride (20 mEq K/liter)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/870307617136949255",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/499510870795889777",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1475393452617802729",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/526779259811209677",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products were stored outside the drug label specifications."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5923870180580026033",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2708183172794967995",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4293490703889273532",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5528307156123729586",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8574929738884873953",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3562280194981168888",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1375692992969000735",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products: FDA laboratory analysis found product to be contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, among others."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6889987536583532215",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9092921149638678407",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab. Hence the sterility of the product cannot be assured."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1681901192266718260",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6752953146064825680",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1092442564719582905",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: Out Of Specification (OOS) result for Assay."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/880552124706594358",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: incomplete or missing data regarding production."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1776311039531520613",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7579662338017367939",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2523720119532731862",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6682384559030334160",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5706317052308509189",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8923600166006653477",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5007327090100214488",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6081002379342632351",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling Incorrect Instructions:  This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8569436652345104574",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6856369821881458342",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4975216298174330233",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6995190908853573836",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Sibutramine and phenolphthalein are not currently marketed in the United States, making this product an unapproved new drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6916240935412328329",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Tablets/Capsules: Potential of Pravastatin tablet fragments in bottles of Valacyclovir 1 gm Tablets."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6028148081480805065",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/932411233529475539",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4804309526329761421",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/808820976677340677",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3609891063322169314",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1790095540766048905",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8911855202833566284",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8599333852752991943",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1568245460947253992",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: AMANTADINE HCL, Capsule, 100 mg may have potentially been mislabeled as one of the following drugs:  ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: W002725, EXP: 6/6/2014;  clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: W002998, EXP: 6/11/2014;  ASPIRIN EC DR, Tablet, 81 mg, NDC 49348098015, Pedigree: W003672, EXP: 2/28/2014;  NIACIN TR, Capsule, 500 mg, N"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2593560516793204124",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5979752129384826765",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9122297284803826350",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4851856758084143460",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6594291594566370481",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9138474149610599268",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7132575828604244815",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8918426301499513668",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1319932464411040860",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or missing package insert:  the affected product was packaged with an out-of-date package insert (PI) dated February 2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/221318596039464384",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2488446281356045331",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; media fill failure at manufacturer"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6204813206019224221",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5696610804951808665",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8514789466782407636",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/535500938967534586",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because the ingredients on the front sticker may not match the actual product in the carton."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6257839735034750469",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6604203809375551043",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/822843178695061180",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/110952495759581795",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4926878072023357117",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2731735105313469750",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4685663675194709031",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Product"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3009433468716297314",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specificattion"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8789060004081577930",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4220185341973768704",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tablet bottles."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3378896524201809710",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; FAMOTIDINE Tablet, 20 mg may be potentially mislabeled as    CARVEDILOL PHOSPHATE ER, Capsule, 20 mg, NDC 00007337113, Pedigree: W003225, EXP: 6/17/2014;  DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: W003506, EXP: 6/21/2014;  FAMOTIDINE, Tablet, 20 mg, NDC 16714036104, Pedigree: W003507, EXP: 6/21/2014;  MYCOPHENOLATE MOFETIL, Capsule, 250 mg, NDC 0037822500"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1313217515812686071",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2966914026615335650",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/807125466588240142",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/255089739141511114",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance: raw material recalled due to stainless steel and other contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4666483827605170431",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/655325061961036829",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/462513346638658439",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured under conditions that could impact its product quality."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1096445014040072361",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; HYOSCYAMINE SULFATE ER Tablet, 0.375 mg may be potentially mislabeled as    SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: W003575, EXP: 6/24/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2417467768967105799",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling:Label Mixup; MELATONIN, Tablet, 1 mg may be potentially mislabeled as    OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W003711, EXP: 6/26/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/774272886333321849",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8988147719620079138",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Product Contains Undeclared API; Incorrect formulation"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3024017178754014875",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3495195552292565427",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6135055023904337178",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; OMEGA-3 FATTY ACID, Capsule, 1000 mg may be potentially mislabeled as    NORTRIPTYLINE HCL, Capsule, 50 mg, NDC 00093081201, Pedigree: AD21790_70, EXP: 5/1/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1969904906187256980",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2171944192554663996",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/247127179553936082",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1497608214591708034",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2587449852097695253",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4175415675100594567",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7184603922938632485",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7438527658399186670",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/57642247718666106",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1712149109145247206",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7651084864701718490",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3160872010014452108",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7150800101904890030",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8997984818338914752",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7874968880731509576",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5849567340444636255",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5994813998653094599",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2658449483295846514",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2390849749745084705",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2252633846410719100",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5618535267015343564",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2466486231086950428",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/145233224761598598",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4196780542329821226",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5638311776022982389",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Some single-use vials may be filled with water rather than the product solution and the firm cannot guarantee the sterility of the water-filled vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6355717142212364473",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1740694425964999632",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical Contamination: FDA analysis found the product to contain methanol, acetaldehyde, and acetal above the limits."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3720766819404400614",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2972075183889940338",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/660513952962568350",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1102543250002933575",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1234977498889291382",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3819959402594443542",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3695537247192808286",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specification and Failed Impurities/Degradation Specifications:  out of specification for inactive content ascorbic acid and MTHFRC-7impurity test"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8309216060679564868",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6257855946111386300",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6925917211625221911",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical Contamination: FDA analysis found 1 lot of MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA (ethyl alcohol 70%) to be below the label claim for ethanol content and to contain methanol."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1508457590502740341",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5605912935943993728",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5151907207797773605",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1393979656638794139",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/216698950834597024",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2431059756439988228",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Temperature Abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/978074343469614274",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7010191538042121875",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5081223102235582558",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/615150850813001547",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4825262524533875588",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1251626105890658143",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6460077287586100378",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phenolphthalein"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6663646028290445678",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5969931315983264170",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7538170679404543489",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: FLECAINIDE ACETATE, Tablet, 100 mg may be potentially mislabeled as the following drug:   COLESTIPOL HCL MICRONIZED, Tablet, 1 g, NDC 59762045001, Pedigree: AD56847_1, EXP: 5/21/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1725727208492952978",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4601122343221742857",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/213916844099382172",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6466460185248198641",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/245020545821731717",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: Temperature abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4093127647695093331",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2450501064749628684",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4097529145070367316",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5220700417589993684",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3984775511222877602",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1771820347314741383",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug and Subpotent Drug: potency failures obtained"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1314468477279680824",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Paddock Laboratories, LLC are recalling one lot   (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a  non-conformity dissolution failure result found during routine stability testing at the 6 month test interval."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4733240281040240701",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7500316074286683933",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/119715835741213627",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Presence of NDMA impurity detected in product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5102565904391154117",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3538725621261110904",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/569709651612491444",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6219776552541948343",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "GMP Deviations: manufacturing of API material did not meet GMP and quality requirements."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7151347861633822814",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2662087322914958556",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8602488976472629784",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovastatin. Lovastatin is an FDA approved drug making this dietary supplement an unapproved new drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2023096200388967778",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations- Lack of Quality Assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3300757442547937559",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2645878299321922119",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/113406432808017985",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Some bottles may contain mixed strengths of the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8726605804167565122",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance; metal particulates were visually observed in the tablets."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4875810011603677538",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: FDA analyses detected the presence of phenolphthalein, N-di-Desmethylsibutramine, and trace amounts of sibutramine and N-Desmethylsibutramine. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6891016095519823735",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations: lack of quality assurance at the API manufacturer."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4519752915123423028",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3560040415784043132",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4254649878222414558",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Concerns with product sterility by the manufacturer of the eye wash irrigating solution."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7437952646629275180",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/361511668132543512",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6121598793798201419",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9128910374170605439",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1978923297206119444",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5721082521137704356",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/950430504400370474",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/198491292883963138",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8862034963755189664",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: SILDENAFIL CITRATE, Tablet, 25 mg may have potentially been mislabeled as the following drug:  PHENobarbital/ HYOSCYAMINE/ ATROPINE/ SCOPOLAMINE, Tablet, 16.2 mg/0.1037 mg/0.0194 mg/0.0065 mg, NDC 66213042510, Pedigree: W003640, EXP: 6/25/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5152088132319480937",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; NIFEDIPINE Capsule, 10 mg may be potentially mislabeled as     MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F), NDC 64376081501, Pedigree: AD22609_7, EXP: 5/2/2014;  NIFEDIPINE, Capsule, 10 mg, NDC 43386044024, Pedigree: AD23082_7, EXP: 9/23/2013."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8919154840340465713",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tartrate tables USP 10 mg"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1804800381222757155",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8656745747920022999",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility: Lack of validation data for sanitization cycles"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3804091836034310382",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8024893346869080467",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3602308182054441867",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications; out-of specification value for homogeneity / phase separation."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8784547378574449330",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4342343230238281583",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1023978312407414319",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: glyBURIDE MICRONIZED, Tablet, 3 mg may have potentially been mislabeled as the following drug:  DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: W003154, EXP: 6/13/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4589070736164723439",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6768837804852047112",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1719221022662843765",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent and Subpotent drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6548002932721794013",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2220534005407539014",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5343501027616207810",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1976633998701294501",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified; Due to an error in the manufacturing procedure, a cylinder in liquid withdrawal service was not marked \u001cSyphon Tube\u001d indicating liquid withdrawal and shipped as a gas withdrawal cylinder."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4196377834157244226",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7480486652863892338",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating \"use for the cure of most jock itch\" rather than \"use for the cure of most athlete's foot\"."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3959948659798033064",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4548303374376805620",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7156902442997211577",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4587743227847873093",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4030193939023709749",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: low out-of-specification dissolution test results observed."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1820298520814061655",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5465395455832276156",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4216340970571680203",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "FAILED DISSOLUTION SPECIFICATIONS"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/791843767175721890",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9222906428059805922",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3553778648603917013",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1584859512002090817",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Concerns with product sterility by the manufacturer of the eye wash irrigating solution."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/150529202784823430",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6554220910642003934",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5757572310430335660",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/630692365754774181",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2799581312305715741",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: NABUMETONE, Tablet, 500 mg may have potentially been mislabeled as the following drug:  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD46429_1, EXP: 5/15/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3787001343421867089",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5234476663416912442",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8684195402458718401",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: High Out Of Specification degradation results."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3119980038927059285",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7057521967548770484",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: Temperature abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/480411883193762179",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2600722204916718453",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5053325414945285651",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8875823208839809553",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2578826859860512707",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1914942452132689877",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/786799191513177424",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8196733104177907812",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/77044880742775769",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5674271140358429152",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1492905594506216748",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6065238165430783693",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Control"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6681525051309194154",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3102873805890494037",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved NDA/ANDA: The products are unapproved drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7845783322590590279",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4695809960034135553",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4762575048112606615",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: There are also CGMP Deviations."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3044548868984091977",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Presence of NDMA impurity detected in product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6484594729071229774",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1179963588127312615",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1079589632980267272",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Crystallization"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4910558732640097841",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6485991236421482748",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: lack of adequate release testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/867872190452043510",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/963913935604993440",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7730603113499093964",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/83030617995930616",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8126651517536332120",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4440332540343096274",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6380879745559320981",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/144723653439079097",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/190620534637121135",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5943648916631051106",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7976455593311045907",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2463390267725765545",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5425169482696214973",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.  If the product is shaken or warmed the white particles goes into the solution."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/293723083197211011",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/302162446670228998",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2464494917872510782",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1359675142966164878",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2112507474873126220",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5698948276666014329",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/248158152011171121",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: This dietary supplement has been found to contain sildenafil, an FDA approved drug for the treatment of male erectile dysfunction making this an unapproved new drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5543138663695722482",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7945090591874624798",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5718722333286950597",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3931842155487905604",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as \"mineral oil , petrolatum \". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1056908010275815781",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: Temperature abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6815951840828990459",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Product contains less Sodium Fluoride than listed on product label."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3759316319569653506",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7358560234442454392",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/684569185537998967",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/784411093478047629",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Packaging defect: blister packaging inadequately sealed."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1660572470462120809",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/144958799957545750",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3916088784823844193",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5332580006076973578",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1232659104039000094",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6647076918072562880",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: potentially contaminated with penicillin"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4828440713060101927",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8880211010646448966",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3410941493983630141",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6507497283764887805",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1447847944616755419",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2680148456300641297",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6181519712976965565",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8366006662348132839",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Customer complaints for leaking bags."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7380844040959250361",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: potentially contaminated with penicillin"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6253449738224550884",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7187666116717432308",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution, 0.1% (30 mL Bottle) following a failure to meet the % RSD requirement in the test for Droplet Size during the 6 month long term stability test station"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3587486688956833210",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2694206862589082587",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/103915713868924780",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7917913277102164594",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6925059999631253681",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed \"5 mL x 50,\" instead of \"10 mL x 50,\""
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9000806366982265534",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2032493010192080440",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6300108709477772567",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: visible crystalline particulates and the discovery of crystalline particulate in a retain sample."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3312214653122391137",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6566674024284106046",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: PHENYTOIN SODIUM ER, Capsule, 30 mg may have potentially been mislabeled as the following drug:  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W003327, EXP: 6/19/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5506843099378336186",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured under conditions that could impact its product quality."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5784823255997998884",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown and total impurity at the 12th month room temperature stability test station"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1204053272162117707",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1561244364922988843",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5313615534925033782",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7353425449120722133",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Impurities/Degradation Products: The product was found to contain a slightly out of specification level of bromides, exceeding the bromides limit for USP Sodium Chloride."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/454396351506308937",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9200830486754588992",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6780050984056098725",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: Ibuprofen is being recalled in response to previous recall"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/798030487407568216",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4015576655035492370",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: preliminary environmental monitoring report exceeds limits, therefore sterility cannot be assured."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5811982256078118373",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6610733891885524320",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7175616899475961061",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4018690629158556480",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4612132844597846209",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8592258452443976296",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3982123762646105362",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Package Insert"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9026848041933058549",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8435593086707952289",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility: Lack of validation data for sanitization cycles"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7292430894180563394",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4369076424171160455",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3309978395713298308",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm did not adequately investigate customer complaints."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3189993510889945638",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6587240819303789574",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1956654487315858252",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter - found in reserve sample vials at the firm."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5569038685815214013",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1443472022932438261",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1768054811115445307",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2643107810326183982",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1128433381310206855",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3256821052236207449",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1845224832799557540",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6722964123789133386",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2365812774855526817",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5930791637488660716",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5755876587615066622",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7735778202937274747",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5037510865366524504",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6942689762027432163",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9184314195971090633",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8946719827052792763",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; diphenhydrAMINE HCl, Tablet, 25 mg may be potentially mislabeled as     ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: AD33897_10, EXP: 5/9/2014;  ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W002774, EXP: 6/6/2014;  PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003511, EXP: 6/21/2014;  VENLAFAXINE, Tablet, 25 mg"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6204783284194343752",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6588861420967839106",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3674046587181268177",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4848588644563202597",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an approved NDA/ANDA: presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and phenolphthalein."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8311842944573328195",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8952123424139634772",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm went out of business and could no longer continue stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3160891244835805941",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4318404211497386751",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: Out of specification for impurities."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4868593575639021811",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8672548745410197563",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6121272220678175903",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2303527139057175559",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3904107516312965404",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1157429423483586760",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2284783057344185",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2145718339072524723",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6726906532897148136",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specification"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2457401731003850597",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3128885682495370555",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7114421300658289619",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8006955713321384004",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8079525963798729736",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1753287250592091855",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7928631525664976303",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6068837586859108846",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2378675205373916965",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5352190974573840176",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3945675688021086900",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Complaints of syringe breakage"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/404888199326523759",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1605384624851643993",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Tablet/Capsule Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8599071242351272254",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6703769736985405058",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/651690536257417662",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5210319473007162210",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility: Lack of validation data for sanitization cycles"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6481975180585984341",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6457283958782729097",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved ANDA/NDA: presence of sibutramine"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2018241912162728491",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4841523879702864745",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/932893144448276626",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP violations noted during the firm's most recent inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1490183212728441718",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2093943912642850078",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Underfilled units."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5554058617903510357",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: There are also CGMP Deviations."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8201538308609663806",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6710458307588433985",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2971079734506505899",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8281536037074342595",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7905768304453022604",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/527711001754493471",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7495054917327794968",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2074380231606225639",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3550424355844471301",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3130222742580391108",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations: Lack of potency testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4008302843810316438",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2824307800266711098",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1142813141352456533",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6650164684303736014",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7079629904659284886",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3791935339253921750",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent drug: out of specification results"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3483813734279583460",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Use of non-food grade lubricant in mixing vessel."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/952546189032429376",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Product.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9207793780382177016",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4525642031335618254",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1860176053121681754",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products; Selected lots of Badger Baby and Kids Sunscreen Lotion were recalled due to microbial contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3607866770069401457",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9106876328622668730",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2211206659671444938",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8885753467179844788",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling:Label Mixup; VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: AD73652_10, EXP: 5/30/2014;  HYOSCYAMINE SULFATE ER, Tablet, 0.375 mg, NDC 43199001401, Pedigree: W003576, EXP: 6/24/2014;  MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD70655_14, EXP: 5/28/2014;  MELATONIN, Tablet, 3 mg, NDC"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5405211768256732780",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: potentially contaminated with penicillin"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8574885084606672772",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1236043666039942121",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of  foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7695680700153184096",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1519005063430050576",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4604401595944914403",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6872208455703033911",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination of Non-Sterile Products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/51086985408065330",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1640415051328168767",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6072312473414204695",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7217672023295826542",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2513186892123918753",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4701010981418368259",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2956315119732606276",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2111500875826595784",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7852960911973289513",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8510928336444912208",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1028362029688879018",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled  with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4832983782025620510",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4533063859408315425",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8001244544286080181",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3601249222347075583",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4845119076040711316",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3489812868828694491",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7341074522472824555",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3975569883174408744",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Stability data does not support expiry."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/341398405442701513",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4374321441451481748",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/380865023867704079",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications: Below specification result for buprenorphine release rate."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5992946972335952784",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/827186348346506484",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7365836569047675069",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3895082885813004196",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: Failure of assay specifications in the capsule."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8600981381846112799",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4844153180812288449",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6656695986693765561",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Superpotent Drug: Stability failure for assay at 6 months test time-point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3385816474500173282",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/96299001398741080",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4267180201162481758",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6942662919773165782",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4240272725379959",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Product contains less Sodium Fluoride than listed on product label."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/848799193121106078",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/551409117624238169",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility: customer complaints received for the presence of leaks."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4391837238336027994",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8189869196326965490",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: SOTALOL HCL, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  DILTIAZEM HCL, Tablet, 120 mg, NDC 00093032101, Pedigree: AD30197_1, EXP: 5/9/2014;  PROPRANOLOL HCL ER, Capsule, 60 mg, NDC 00228277811, Pedigree: AD54605_4, EXP: 5/20/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2227476994621402652",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3202925646239676460",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4717151341814130386",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7318042214208798068",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5804915747283553758",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specification"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6126084707546764376",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5892559675301438459",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1911328013464567806",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/86570348399702649",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3161334286730679621",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3312745246094232764",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications; three month stability time point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3659390904870772626",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7913856060397561225",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9082652135188941729",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2323567000396722020",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6027285311141684691",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6597559151259162576",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7417088806130813289",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; product has the potential to leak."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4576116828039010355",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2987126102226857030",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4304938930654646794",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/465356910860324787",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7819120239039670232",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Non-Sterility: Out of specification results for the sterility test for microbial contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5246518816596771665",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3070072058419991737",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1245406076056372403",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/702295045451047162",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8374155116622959289",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6881746128778993052",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1672348159638694171",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4828232917996212801",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6848513816747356216",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7337733855620927115",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Next Advanced Antibacterial Hand Sanitizer was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3947927082058403907",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations: Out of specification results for micro in hand soap products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4361845737108872835",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1862834053316787291",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7773860314772784832",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3801973635739011813",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1830341716058408055",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling:Label Mixup; ZINC SULFATE Capsule, 220 mg may be potentially mislabeled as    CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD52778_10, EXP: 5/20/2014;  CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: W003638, EXP: 6/25/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5976190877049613299",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4345974743262200128",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6780732783606292246",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5494246804229704261",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8273643561775248295",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed impurities/degradation specifications: Purity readings for oxygen were out of specification."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1971520662788227984",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: Temperature abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7219561343306685358",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Tablets/Capsules."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8096994186035048767",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7911913443890490842",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2395250721566481373",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: Low dissolution results were obtained during stability testing"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1486296305654765434",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6142637192711171678",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Substance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7943436457673312877",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4494449904627573605",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: leaking bags"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3955711492672179027",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4741555718588280467",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5807110359766546636",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: PERPHENAZINE, Tablet, 8 mg may have potentially been mislabeled as the following drug:  NIFEdipine, Capsule, 10 mg, NDC 59762100401, Pedigree: AD52778_55, EXP: 5/20/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7438913159857266858",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2162029150018319029",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Container: Confirmed customer complaints of leaking bottles."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3306528213012220149",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/548898001590757248",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; COENZYME Q-10 Capsule, 100 mg may be potentially mislabeled as    ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD30180_13, EXP: 5/9/2014;  ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: AD33897_1, EXP: 5/9/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD37056_1, EXP: 5/10/2014;  METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 576640"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5479232566060021295",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Out of specification for volume and compromised container closure."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5726868240992351708",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4040241833474742646",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1329284162774571968",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A.."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/584125729254737492",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4187600106713579905",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5676131448971395090",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5561028994546941113",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: FLUCONAZOLE, Tablet, 200 mg may have potentially been mislabeled as one of the following drugs:  VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD65475_10, EXP: 5/28/2014;  FLUCONAZOLE, Tablet, 100 mg, NDC 68462010230, Pedigree: W003064, EXP: 6/12/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2550754045069763297",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2779807000609768061",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Delivery System: One lot exceeded the mechanical peel specification"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5423949778936405437",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7235941287482762198",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Sterility of product is not assured."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/66360009186297031",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1277625452476818102",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1897051234804533551",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3176207947426967671",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3771838544264333003",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6443094582852906059",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; PROPRANOLOL HCL, Tablet, 10 mg may be potentially mislabeled as    PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: AD52778_70, EXP: 5/21/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5893326288380482547",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9081064596273475359",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5532118654308936721",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1396635294283147577",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7975416540368056534",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1112394949398489627",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2741100406574262343",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7584218321069905722",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3543994620605935726",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, King Bio Inc., due to water contamination issues that could potentially affect the quality of this product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4359882723004269651",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/207698867015919738",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; media fill failure at manufacturer"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5101058828775077661",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3450213514466554403",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8174232672460765929",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility: Lack of validation data for sanitization cycles"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8667424537466132224",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/439547629257852353",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3060698260435226912",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3736690743238649517",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5855788380455879197",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Error on Declared Strength: Assay value on the label is incorrect."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8094415693636661494",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1776851647173176362",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug:  ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD60272_70, EXP: 5/22/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2845753967457132962",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4665228673232607514",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5658273276313147635",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9153031696169683805",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose  vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml  multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/219164577916520289",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6472191523837515629",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1921637079920383958",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2273677172561869419",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4859326836639100431",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8142661991236998631",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7980330501869601697",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1974181984681623483",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1206085704577584235",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7810487455928626104",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Subpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1967115692604667357",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Content Uniformity Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6133968909350564007",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4308512473708620652",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1102023555993887318",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6591725625998264168",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/218418596035146660",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2150566307569001448",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2115013303101624095",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5782451627514701206",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2820265205593836324",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5456037845297307013",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6730607084477073492",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6590359796584267486",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1528684812105043862",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm went out of business and could no longer continue stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1390928786270389761",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1249042915159075060",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Sterility of product is not assured."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8071332324481361482",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date.  The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5063486099511788002",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Missing Label-Primary packaging label (i.e. blister card) is blank and contains no product information (e.g. product name, strength, lot number, expiry)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2589585735257093193",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2618641840314422808",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1224308298099071637",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7805890844669741538",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1827800446294855597",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets.."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7002005065341049048",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "This recall of LIPTRUZET is being initiated due to  packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7767674099949636286",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6421046544370814463",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/802353277516011323",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6207215825000821222",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4215782744992548530",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5981827750348432717",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9014846806144910241",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7552117853905955634",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6658254833523180445",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: recalling drug products following an FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2411093456480000478",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Moisture Limits: Out of specification for water content"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2889474973979051573",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3168254570326074609",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5273245882125357156",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4701698022059088733",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: TRI-BUFFERED ASPIRIN, Tablet, 325 mg may have potentially been mislabeled as the following drug:  ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP, Capsule, 65 mg/100 mg/325 mg, NDC 44183044001, Pedigree: W003596, EXP: 5/31/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/961621477717987553",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4538705385324184281",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7786460883981253678",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; container closure issues with the bulk batch."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7483666591034232468",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3724222658847333314",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9154079486449725307",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/231247494406237959",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3684473515189917511",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications: failure of dissolution test observed at nine month time point."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3856186205927465774",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7749554141085876186",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5127818400268238480",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7567765359486034891",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP DEVIATIONS"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7186999475051394869",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8494692318245838651",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6915699957444766852",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2668989100540572825",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm went out of business and could no longer continue stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9012885002082907428",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup; carBAMazepine ER Tablet, 200 mg may be potentially mislabeled as    ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: AD60272_1, EXP: 5/22/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1301868974062475192",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6085816991586163718",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8055078509795384668",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3876268022333042201",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5385648701018475899",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1551966173709212992",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed without an Approved NDA/ANDA: products were found to contain undeclared sildenafil"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5652288039196341971",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2421440890687676852",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2798856790562113068",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3234473925676585424",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8009407351813919406",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4024754069136194330",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of assurance of sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2367167435540020125",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7411640827213560775",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5902295057588828394",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5970643956067790465",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: MINOCYCLINE HCL, Capsule, 100 mg may have potentially been mislabeled as the following drug:  PROGESTERONE, Capsule, 100 mg, NDC 00591396401, Pedigree: AD73611_4, EXP: 5/30/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3220566464553225985",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4059109629018375519",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: product sterility cannot be guaranteed."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8719443964613560659",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1045597733887960152",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4744804525383498128",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethasone Sodium Phosphate 7 mg/mL INJ SUSP because of the potential of drug clumps in the vial of the sterile drug product and larger particle sizes."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/418929400566429379",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2048391439144541711",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/ Degradation Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2408084107977286333",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial contamination"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8462390381290478538",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cMGP Deviations: Drug products repackaged into pouches without supporting stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3308938622265396435",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3504142143160994634",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: Potential leakage of bags."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3542734398608041525",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: There are also CGMP Deviations."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2262814547967842146",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: product held outside appropriate storage temperature conditions."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2570782316828393775",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5829207240328864854",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Dissolution Specifications"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5898399150036708394",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7521460749435599233",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: DRONEDARONE HCL, Tablet, 400 mg may be potentially as the following drug:  METHYLERGONOVINE MALEATE, Tablet, 0.2 mg, NDC 43386014028, Pedigree: AD52778_40, EXP: 5/20/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4469176464341034190",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: due to shipment of rejected units."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7234652138346976662",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6361442044189741034",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1172494217521998917",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of sterility assurance."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1662894131289718096",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP deviations- Lack of Quality Assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7444151208341206574",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP deviations: Temperature abuse"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7189870077174860209",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8434287829230737383",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2430909607703648061",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted  from the product carton, primary label is correct."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1996045866837604011",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations:"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8550422134425190541",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Labeling: Label Mixup: LACTOBACILLUS ACIDOPHILUS, Tablet, 35 MILLION may have potentially been mislabeled as the following drug:  REPAGLINIDE, Tablet, 1 mg, NDC 00169008281, Pedigree: W003924, EXP: 6/28/2014."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/9191035353714359939",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4954023695438095648",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia contaminans and/or yeast and mold."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2418288982795059167",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2081649352942348274",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: recalling drug products following an FDA inspection."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/3210753272608970587",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities)."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8404214759353557102",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: product sterility cannot be guaranteed."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/506949931979825049",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7471073216436811476",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/732811141567878642",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1811674826730437845",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Intermittent exposure to temperature excursion during storage."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8385887789433874617",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class III"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/8249937228450435289",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/773622596342044557",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: Firm went out of business and could no longer continue stability studies."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1875568148752541895",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/2047585460255193717",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/4131843050274383058",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/1291252698137508810",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Assurance of Sterility; Immediate product pouches may not be properly sealed."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7695521103268253837",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/5666669798667484646",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "CGMP Deviations: finished products were manufactured with poor quality water."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6298535418388525736",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/901679399558518357",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Lack of Processing Controls"
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/6404191336835230191",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7194270257118630941",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class II"
      }
    ]
  },
  {
    "@id": "http://example.org/fda/7402034824164743040",
    "http://example.org/fda/hasRecallReason": [
      {
        "@value": "Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility."
      }
    ],
    "http://example.org/fda/hasRecallType": [
      {
        "@value": "Class I"
      }
    ]
  }
]